Αποτελέσματα Αναζήτησης
20 Σεπ 2021 · With this acquisition, Arbor is now a wholly-owned subsidiary of Azurity. The two companies will begin to integrate their operations over the coming months and will operate as Azurity post-integration.
Arbor Pharmaceuticals, LLC is a subsidiary of Azurity Pharmaceuticals, Inc. Click to learn more at Azurity.com or please wait to be automatically directed. GO NOW > PP-AZ-US-0004
24 Αυγ 2021 · WOBURN, MA & ATLANTA, GA (August 24, 2021) – Azurity Pharmaceuticals, Inc. (“Azurity”) and Arbor Pharmaceuticals, Inc. (“Arbor”) today announced they have entered into a definitive agreement in which Azurity will be acquiring Arbor from existing investors including JW Asset Management and KKR.
24 Αυγ 2021 · Arbor Pharmaceuticals is a specialty pharmaceutical company with a diversified portfolio of branded products across multiple therapeutic areas for the cardiovascular, pediatric, and hospital markets as well as generic products through its Wilshire division.
24 Αυγ 2021 · Azurity Pharmaceuticals, Inc. (“Azurity”) and Arbor Pharmaceuticals, Inc. (“Arbor”) today announced they have entered into a definitive agreement in which Azurity will be acquiring Arbor from existing investors including JW Asset Management and KKR.
19 Σεπ 2021 · Azurity Pharmaceuticals completed the acquisition of Arbor Pharmaceuticals Inc. from JW Asset Management, LLC and KKR & Co. Inc. (NYSE:KKR) on September 20, 2021. With this acquisition, Arbor is now a wholly-owned subsidiary of Azurity.
Dec 4 (Reuters) - KKR & Co LP has agreed to acquire a significant minority stake in Arbor Pharmaceuticals LLC, in a deal that values the privately held specialty drugmaker at more than $1...
